Ironwood Pharmaceuticals, Inc. - Class A (IRWD) — Analysis Summary

Ironwood Pharmaceuticals, Inc. - Class A (IRWD) has a market cap of $730.88M with year-over-year revenue growth of -20.6%. Net margin stands at 0.3%. The stock trades at a P/E ratio of 830.5.

Key Takeaways

• Revenue changed -20.6% year-over-year
• Net margin of 0.3%
• P/E ratio of 830.5

Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, IRWD posted revenue growth of -20.6% and trades at a P/E of 830.5.